Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)
<p><strong>Background:</strong> Strong and broad antiviral T-cell responses targeting vulnerable sites of HIV-1 will likely be a critical component for any effective cure strategy.</p> <p><strong>Methods:</strong> BCN01 trial was a phase I, open-label, non-r...
| প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| বিন্যাস: | Journal article |
| প্রকাশিত: |
Elsevier
2019
|